NASDAQ:IBRX

Immunitybio Stock Insider Trading

etoro logo Buy IBRX
*Your capital is at risk
$7.18
-0.0500 (-0.692%)
At Close: Jun 03, 2026

ImmunityBio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -8.26. In total, the insiders bought 19.2M and sold 1.29M IBRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-8.26
Buy 19.2M shares
Sell 1.29M shares
70% Buy Activity
Strong Negative Correlation
Sell Signal Medium Confidence
Feb 23, 2026

Analysis Breakdown:

  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 10, 2026
Sell
Common Stock
F-InKind
Lauer Regan J
Chief Accounting Officer
Officer 2 257
Value: $15.6K
Feb 10, 2026
Buy
Common Stock
M-Exempt
Soon-shiong Patrick
See Remarks
Officer 274 122
Value: $1.80M
Feb 10, 2026
Sell
Common Stock
F-InKind
Soon-shiong Patrick
See Remarks
Officer 118 560
Value: $821.6K
Feb 10, 2026
Buy
Restricted Stock Units
M-Exempt
Soon-shiong Patrick
See Remarks
Officer 274 122
Value: $1.80M
Feb 10, 2026
Buy
Common Stock
M-Exempt
Sachs David C.
Chief Financial Officer
C-Suite Officer 82 236
Value: $539.5K
Feb 10, 2026
Sell
Common Stock
F-InKind
Sachs David C.
Chief Financial Officer
C-Suite Officer 42 643
Value: $295.5K
Feb 10, 2026
Buy
Restricted Stock Units
M-Exempt
Sachs David C.
Chief Financial Officer
C-Suite Officer 82 236
Value: $539.5K
Feb 10, 2026
Buy
Common Stock
M-Exempt
Lauer Regan J
Chief Accounting Officer
Officer 5 482
Value: $36.0K
Feb 10, 2026
Buy
Restricted Stock Units
M-Exempt
Adcock Richard
CEO & President
CEO / President 274 122
Value: $1.80M
Feb 10, 2026
Sell
Common Stock
F-InKind
Adcock Richard
CEO & President
CEO / President 140 048
Value: $970.5K
Jan 20, 2026
Sell
Common Stock
S-Sale
Selecky Christobel
Director
Director 25 000
Value: $187.7K
Jan 20, 2026
Buy
Common Stock
M-Exempt
Selecky Christobel
Director
Director 25 000
Value: $74.5K
Jan 20, 2026
Buy
Stock Option (right to buy)
M-Exempt
Selecky Christobel
Director
Director 25 000
Value: $74.5K
Jan 20, 2026
Sell
Common Stock
S-Sale
Simon Barry J.
Director
Director 76 967
Value: $503.4K
Jan 20, 2026
Sell
Common Stock
S-Sale
Simon Barry J.
Director
Director 75 000
Value: $590.9K
Jan 16, 2026
Sell
Common Stock
S-Sale
Selecky Christobel
Director
Director 50 000
Value: $250.0K
Jan 16, 2026
Buy
Common Stock
M-Exempt
Selecky Christobel
Director
Director 50 000
Value: $149.0K
Jan 16, 2026
Buy
Stock Option (right to buy)
M-Exempt
Selecky Christobel
Director
Director 50 000
Value: $149.0K
Dec 31, 2025
Buy
Restricted Stock Units
M-Exempt
Sachs David C.
Chief Financial Officer
C-Suite Officer 30 397
Value: $60.2K
Dec 31, 2025
Sell
Common Stock
F-InKind
Sachs David C.
Chief Financial Officer
C-Suite Officer 15 435
Value: $30.6K
Dec 31, 2025
Buy
Common Stock
M-Exempt
Sachs David C.
Chief Financial Officer
C-Suite Officer 30 397
Value: $60.2K
Dec 31, 2025
Buy
Common Stock
M-Exempt
Adcock Richard
CEO & President
CEO / President 34 483
Value: $68.3K
Dec 31, 2025
Sell
Common Stock
F-InKind
Adcock Richard
CEO & President
CEO / President 17 510
Value: $34.7K
Dec 31, 2025
Buy
Restricted Stock Units
M-Exempt
Adcock Richard
CEO & President
CEO / President 34 483
Value: $68.3K
Dec 12, 2025
Buy
Common Stock
J-Other
Wendel Bruce
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IMMUNITYBIO, INC.
ImmunityBio
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE